Cefditoren: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) |
||
| Line 26: | Line 26: | ||
'''| [[Cefditoren drug interactions|Drug Interactions]]''' | '''| [[Cefditoren drug interactions|Drug Interactions]]''' | ||
'''| [[Cefditoren overdosage|Overdosage]]''' | '''| [[Cefditoren overdosage|Overdosage]]''' | ||
'''| [[Cefditoren dosage and administration|Dosage and Administration]]''' | '''| [[Cefditoren dosage and administration|Dosage and Administration]]''' | ||
'''| [[Cefditoren how supplied|How Supplied]]''' | '''| [[Cefditoren how supplied|How Supplied]]''' | ||
Revision as of 01:44, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cefditoren is a third-generation cephalosporin antibiotic for oral use. It is commonly marketed under the trade name Spectracef by Cornerstone BioPharma.
Category
Cephasporin, Third-Generation
US Brand Names
SPECTRACEF®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages